Raleigh · Biotech · North Carolina

10 Raleigh biotech startups

As of November 2026, Triangle Startups tracks 10 biotech startups headquartered in Raleigh, the state capital and the Triangle's largest city. In the twelve months to November 2026, Raleigh biotech startups disclosed $133.3 million across 3 funding rounds.

Latest recorded activity

Directory snapshot

Raleigh biotech startups by stage

Of 3 startups with a recorded funding stage, 1 are at grant, pre-seed, or seed.

tracked startups
10
hiring now
0
grant through seed
1
By stageGrowth1Pre-seed1Series A1

All 10 biotech startups headquartered in Raleigh

Aer Therapeutics

Aer Therapeutics

Biotech

Biotech developing inhaled therapies that target mucus obstruction in chronic lung disease. Spun out of UCSF.

B

Bedrock Therapeutics

Biotech

Develops engineered AAV vectors and gene therapies, with programs in corneal transplant rejection, ocular graft-versus-host disease, macular degeneration and rheumatoid arthritis.

Belhaven Biopharma

Belhaven Biopharma

Biotech · Growth

Developing Nasdepi, a dry powder nasal epinephrine product for severe allergic reactions.

ChromaGenix

ChromaGenix

Biotech

Bioprocessing tooling startup developing synthetic peptide ligands for affinity chromatography of advanced biologic modalities (gene therapies, mRNA vaccines, exosomes, lipid nanoparticles, AAV vectors). Formed in 2025-04-22 by BioProcess360 Partners through transfer of IP, assets, and personnel from LigaTrap Technologies.

Gemelli Biotech

Gemelli Biotech

Biotech

At-home precision diagnostics for GI diseases.

M

MicroBioCol

Biotech

Raleigh software startup building CadeLume, an auditable AI proxy gateway designed for regulated biopharma teams.

N

NOBiotics, LLC

Biotech

Develops nitric oxide based therapeutics and medical devices, including topical therapies and dressings for wound infection control.

O

Oncurie

Biotech

NC State spinout developing chelator-based radiopharmaceuticals that carry radioactive isotopes to cancer cells, starting with ovarian cancer.

Slate Medicines

Slate Medicines

Biotech · Series A

Raleigh biotech developing therapeutics for migraine and other headache disorders. Lead program SLTE-1009 is a subcutaneous anti-PACAP monoclonal antibody in-licensed from DartsBio Pharmaceuticals, targeting a pathway distinct from CGRP.

S

Synoxa Sciences

Biotech · Pre-seed

Discovery-stage antibiotic small-molecule company developing two novel chemical classes (4-oxazolidiones and a class targeting multidrug-resistant Gram-negative pathogens). NC State spinout from the Joshua Pierce lab.

Exited biotech companies headquartered in Raleigh

These companies have been acquired, taken private, or taken public, so each is listed with its exit and left out of the startup count above.

Browsing is free. Opening a company shows the basics; founders, funding, and signals are in the full profile behind a free account. Open roles across Triangle companies are tracked on the jobs page. Numbers refresh from the database.